课题基金 / 基金详情

Therapeutics/Vaccine Teams

Therapeutics/Vaccine Teams
治疗/疫苗团队
批准号:
8161305
负责人:
CHARLES NICOLETTE
金额:
$1506.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-30 至 2013-05-31

项目摘要

项目成果

CHARLES NICOLETTE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Each HIV Vaccine Team shall be required to perform the following activities and provide the following resources: 1. Develop a specific therapeutic HIV vaccine concept into a product capable of being tested in a clinical trial. 2. Provide for the production of vaccine products under Good Manufacturing Practices (GMP). 3. Provide the requisite infrastructure, facilities, and resources for performing all phases of the contract. 4. Design and implement one or more clinical protocols, independently or in collaboration with a DAIDS-funded HIV/AIDS clinical trials network,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVD
  • 批准号:
    8930878
  • 项目类别:
  • 资助金额:
    $50.51万
  • 财政年份:
    2006
  • 负责人:
    CHARLES NICOLETTE
  • 依托单位:
Therapeutics/Vaccine Teams
  • 批准号:
    8328470
  • 项目类别:
  • 资助金额:
    $602.78万
  • 财政年份:
    2006
  • 负责人:
    CHARLES NICOLETTE
  • 依托单位:
HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVD
  • 批准号:
    8748839
  • 项目类别:
  • 资助金额:
    $541.53万
  • 财政年份:
    2006
  • 负责人:
    CHARLES NICOLETTE
  • 依托单位:
海外基金